doxazosin

Generic: doxazosin

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 4 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-927
Product ID 71610-927_3ab22051-bf7b-5122-e063-6294a90a4f64
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA019668
Listing Expiration 2026-12-31
Marketing Start 2023-01-18

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610927
Hyphenated Format 71610-927

Supplemental Identifiers

RxCUI
197627
UNII
86P6PQK0MU

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin (source: ndc)
Application Number NDA019668 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (71610-927-53)
  • 90 TABLET in 1 BOTTLE (71610-927-60)
  • 180 TABLET in 1 BOTTLE (71610-927-80)
source: ndc

Packages (3)

Ingredients (1)

doxazosin mesylate (4 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3ab22051-bf7b-5122-e063-6294a90a4f64", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197627"], "spl_set_id": ["3ab222b7-74cc-5343-e063-6294a90a9616"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71610-927-53)", "package_ndc": "71610-927-53", "marketing_start_date": "20250718"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-927-60)", "package_ndc": "71610-927-60", "marketing_start_date": "20250718"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (71610-927-80)", "package_ndc": "71610-927-80", "marketing_start_date": "20250718"}], "brand_name": "Doxazosin", "product_id": "71610-927_3ab22051-bf7b-5122-e063-6294a90a4f64", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-927", "generic_name": "doxazosin", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "4 mg/1"}], "application_number": "NDA019668", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20230118", "listing_expiration_date": "20261231"}